Clinical Trials Logo

Filter by:
NCT ID: NCT03944161 Terminated - Malnutrition Clinical Trials

Effectiveness and Cost-Effectiveness Study of Medical Nutrition in Malnourished Patients in Spain

COSENUT
Start date: November 20, 2019
Phase: N/A
Study type: Interventional

The present study aims to evaluate the use of oral nutritional supplementation in persons with some clinical conditions presenting malnutrition in some extent.

NCT ID: NCT03943290 Terminated - Clinical trials for Charcot-Marie-Tooth Disease

Extension Study to Evaluate the Long-Term Effects of ACE-083 in Patients With Facioscapulohumeral Muscular Dystrophy (FSHD) and Charcot-Marie Tooth (CMT) Disease Types 1 and X (CMT1 and CMTX)

Start date: May 10, 2019
Phase: Phase 2
Study type: Interventional

This is an open-label, multicenter, phase 2 extension study to evaluate the safety, tolerability, PK, PD, and efficacy of ACE-083 in subjects with FSHD previously enrolled in Study A083-02 and subjects with CMT1 and CMTX previously enrolled in Study A083-03. This study will be conducted in two Parts: Part 1, which is a loading phase of 6 months' duration, and Part 2, the maintenance phase, which will last up to 24 months.

NCT ID: NCT03943147 Terminated - Lupus Nephritis Clinical Trials

An Investigational Study to Evaluate the Safety and Effectiveness of BMS-986165 With Background Treatment in Participants With Lupus Nephritis

Start date: July 15, 2019
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the safety and effectiveness of BMS-986165 compared with placebo with regard to measures of kidney function in participants with lupus nephritis (LN).

NCT ID: NCT03942211 Terminated - Clinical trials for Sarcoidosis-associated Pulmonary Hypertension

A Study in Participants With Sarcoidosis-associated Pulmonary Hypertension (SAPH) to Assess the Efficacy and Safety of Oral Selexipag

SPHINX
Start date: February 26, 2021
Phase: Phase 2
Study type: Interventional

Oral selexipag is commercially available in several countries for the treatment of a particular group of pulmonary hypertension (PH) called pulmonary arterial hypertension (PAH). The aim of the present study is to investigate whether selexipag could be helpful to treat patients with another form of PH called sarcoidosis-associated pulmonary hypertension (SAPH).

NCT ID: NCT03938545 Terminated - Clinical trials for Graves' Ophthalmopathy (GO)

ASCEND GO-2: Study of RVT-1401 for the Treatment of Participants With Active, Moderate to Severe Graves' Ophthalmopathy ( GO )

Start date: July 23, 2019
Phase: Phase 2
Study type: Interventional

The purpose of the current study is to assess the efficacy and safety/tolerability of three dose regimens of RVT-1401 in the treatment of active, moderate to severe GO participants. In addition, the study is designed to characterize the effect of RVT-1401 exposure on reduction in anti-TSHR IgG

NCT ID: NCT03938272 Terminated - Clinical trials for Hyperoxaluria, Primary

An Extension Study to Evaluate the Long-term Efficacy and Safety of Oxabact in Patients With Primary Hyperoxaluria

ePHex-OLE
Start date: March 14, 2019
Phase: Phase 3
Study type: Interventional

Open label extension study of Oxabact OC5 in patients with primary hyperoxaluria

NCT ID: NCT03933410 Terminated - Urea Cycle Disorder Clinical Trials

UNLOCKED: A Phase 2, Open-label Trial With KB195 in Subjects With a Urea Cycle Disorder

UNLOCKED
Start date: September 17, 2019
Phase: Phase 2
Study type: Interventional

UNLOCKED: A Phase 2 Trial to Evaluate the Efficacy and Safety of KB195 in Subjects with a Urea Cycle Disorder with Inadequate Control on Standard of Care

NCT ID: NCT03931551 Terminated - Clinical trials for Advanced Breast Cancer

Olaparib+Trastuzumab in HER2[+],Breast Cancer Susceptibility Gene (BRCA) Mutated Advanced Breast Cancer

OPHELIA
Start date: April 30, 2019
Phase: Phase 2
Study type: Interventional

This is a multicenter, open-label, single-arm, phase II clinical trial, phase II trial will evaluate the efficacy and safety of olaparib plus trastuzumab in patients with HER2[+], BRCA-mutated advanced breast cancer

NCT ID: NCT03930459 Terminated - Liver Transplant Clinical Trials

Efficacy of Ex-situ Normothermic Perfusion Versus Cold Storage in the Transplant With Steatotic Liver Graft.

ORGANOXLAFE
Start date: April 26, 2019
Phase: N/A
Study type: Interventional

Prospective, randomized, controlled clinical trial to determine the overall efficacy of normothermic machine perfusion (NMP) for steatotic liver preservation versus traditional static cold storage (SCS), in 50 liver transplant recipients with 1-year follow-up.

NCT ID: NCT03920254 Terminated - Clinical trials for Ulcerative Colitis (UC)

TD-1473 Long-Term Safety (LTS) Ulcerative Colitis (UC) Study

Start date: July 23, 2020
Phase: Phase 2/Phase 3
Study type: Interventional

A 3-Year Multi-Center, Long-Term Safety (LTS) Study to Evaluate the Safety and Tolerability of TD-1473 in Subjects with Ulcerative Colitis who have participated in the Maintenance Study of Protocol 0157